论文部分内容阅读
目的:评估奥曲肽治疗重症胰腺炎的临床治疗效果。方法:随机选取2014年2月至2016年2月我院收治的58例重症胰腺炎患者临床资料分析,根据数字随机法把58例患者分成对照组与观察组,对照组给予常规治疗,观察组在对照组治疗基础上增加奥曲肽治疗,比较两组患者疗效和治疗前后血糖、血淀粉酶、尿淀粉酶及C反应蛋白等情况。结果:观察组治疗总有效率86.2%,对照组总有效率58.6%,观察组疗效明显高于对照组,两组对比差异显著(P<0.05);观察组血糖、血淀粉酶、尿淀粉酶及C反应蛋白等指标恢复情况明显优于对照组,两组对比差异显著(P<0.05)。结论:奥曲肽治疗重症胰腺炎疗效理想,可以缩短生化指标恢复时间,值得推广应用。
Objective: To evaluate the clinical effect of octreotide in treating severe pancreatitis. Methods: Fifty-eight patients with severe acute pancreatitis treated in our hospital from February 2014 to February 2016 were randomly selected. Fifty-eight patients were divided into control group and observation group according to the digital randomization method. The control group was given routine treatment and the observation group In the control group based on the increase of octreotide treatment, the efficacy of the two groups were compared and before and after treatment of blood glucose, blood amylase, urinary amylase and C-reactive protein and so on. Results: The total effective rate was 86.2% in the observation group and 58.6% in the control group. The curative effect in the observation group was significantly higher than that in the control group (P <0.05). The levels of blood glucose, blood amylase, urine amylase And C-reactive protein and other indicators of recovery was significantly better than the control group, significant difference between the two groups (P <0.05). Conclusion: Octreotide is effective in treating severe pancreatitis, which can shorten the recovery time of biochemical indexes and is worth popularizing and applying.